|
|
Volumn 1, Issue 3, 2007, Pages 164-175
|
|
Targeting the human thioredoxin system by diverse strategies to treat cancer and other pathologies.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOXIDANT;
CARRIER PROTEIN;
RECOMBINANT PROTEIN;
THIOREDOXIN;
TRANSCRIPTION FACTOR;
TUMOR PROTEIN;
TXNIP PROTEIN, HUMAN;
APOPTOSIS;
CELL SURVIVAL;
CYSTIC FIBROSIS;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG RESISTANCE;
ENTERITIS;
GENE EXPRESSION REGULATION;
GENE TRANSFER;
GENETICS;
HUMAN;
LIVER DISEASE;
METABOLISM;
MUTATION;
NEOPLASM;
OXIDATION REDUCTION REACTION;
OXIDATIVE STRESS;
PATENT;
PROTEIN STABILITY;
REVIEW;
ANTIOXIDANTS;
APOPTOSIS;
CARRIER PROTEINS;
CELL SURVIVAL;
CYSTIC FIBROSIS;
DRUG RESISTANCE, NEOPLASM;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE TRANSFER TECHNIQUES;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
LIVER DISEASES;
MUTATION;
NEOPLASM PROTEINS;
NEOPLASMS;
OXIDATION-REDUCTION;
OXIDATIVE STRESS;
PATENTS AS TOPIC;
PROTEIN STABILITY;
RECOMBINANT PROTEINS;
THIOREDOXINS;
TRANSCRIPTION FACTORS;
|
|
EID: 62349141762
PISSN: 18722156
EISSN: None
Source Type: Journal
DOI: 10.2174/187221507782360227 Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
